What You Need To Know
JFK University Medical Center announced today the availability of aquablation therapy for men with symptoms of enlarged prostate, also known as benign prostatic hyperplasia (BPH). JFK University Medical Center is one of the first hospitals in New Jersey behind Hackensack University Medical Center to offer this advanced non-surgical treatment option that uses the power of high velocity water, delivered with an image-guided robotic arm, controlled by a surgeon, to safely and effectively treat patients suffering from lower urinary symptoms due to BPH.
“Aquablation therapy is precise, predictable and consistent and involves removing prostate tissue that is causing the particular urinary symptoms,” said Michael S. Lasser, MD, FACS, chair of Robotic Surgery at JFK University Medical Center. “No incision is made during the procedure but rather the prostate is reached through the urethra, using a heat-free waterjet controlled by robotic technology to remove prostate tissue. The procedure can be done on men who have prostates of varying size.”
Benign prostatic hyperplasia is a condition in men in which the prostate gland is enlarged and not cancerous. Symptoms of BPH include urinary urgency and frequency, slower stream, waking up frequently at night to urinate, and the sensation of incomplete emptying of the bladder.
For more information about aquablation for BPH or other urological conditions, please click here to register for our webinar on November 2, from 1:00p.m. - 2:00p.m. which will be led by Dr. Nakhoa.